Amnion Life LLC
Amniobed, a Ground-Breaking Medical Device to Save Preterm Infants Lives
https://wefunder.com/amnion.life
Total raised on Wefunder: 474883
Total investors: 415
Quick facts
- In Amniobed, the preterm infant is partially submerged in synthetic amniotic fluid.
- Amniobed is intended to prevent hypothermia in preterm infants and decrease environmental heat loss.
- Hypothermia leads to poor medical outcomes and an increased chance of infant death.
- Strong patent portfolio with multiple patents in the US, China, and Japan and pending in Europe.
- Studies have shown 40% of infants admitted to the NICU from L&D are hypothermic in 1st hour of life.
- Significant calorie loss in the NICU leads to diminished weight gain and longer hospital stays
- 3 Years of R&D. Designed, sourced, procured, and assembled Amniobed Golden Hour plus software.
- The project was placed on pause in 2020 due to COVID-19. Raising capital to finish the prototype.